Cargando…
Advanced Therapy Medicinal Products for the Eye: Definitions and Regulatory Framework
Advanced therapy medicinal products (ATMPs) are a group of innovative and complex biological products for human use that comprises somatic cell therapy medicinal products, tissue engineered products, gene therapy medicinal products, and the so-called combined ATMPs that consist of one of the previou...
Autores principales: | López-Paniagua, Marina, de la Mata, Ana, Galindo, Sara, Blázquez, Francisco, Calonge, Margarita, Nieto-Miguel, Teresa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8000705/ https://www.ncbi.nlm.nih.gov/pubmed/33800934 http://dx.doi.org/10.3390/pharmaceutics13030347 |
Ejemplares similares
-
Goals and Challenges of Stem Cell-Based Therapy for Corneal Blindness Due to Limbal Deficiency
por: Calonge, Margarita, et al.
Publicado: (2021) -
Subconjunctival injection of mesenchymal stem cells for corneal failure due to limbal stem cell deficiency: state of the art
por: Galindo, Sara, et al.
Publicado: (2021) -
A comparison of stem cell-related gene expression in the progenitor-rich limbal epithelium and the differentiating central corneal epithelium
por: Nieto-Miguel, Teresa, et al.
Publicado: (2011) -
In Vivo Confocal Microscopy in Limbal Stem Cell Deficiency After Mesenchymal Stem Cell Transplantation: A Sub-analysis from a Phase I–II Clinical Trial
por: Pérez, Inmaculada, et al.
Publicado: (2023) -
Corneal Regeneration Using Adipose-Derived Mesenchymal Stem Cells
por: Alió del Barrio, Jorge L., et al.
Publicado: (2022)